Short description:
Out licensing
Drug notes:
Contact us to add description: recruit@workinbiotech.com
Long description:
Braeburn is developing drugs to fight against opioid addiction. Opioid overdose and misuse are a significant public health crisis in the US today affecting 2 million people. To treat opioid addiction, Braeburn is developing a FluidCrystal® injection depot technology, a next generation delivery system that includes a lipid-based liquid with a dissolved active ingredient. Braeburn is adapting this technology to deliver buprenorphine, a medication that normalizes brain chemistry and blocks the euphoric effects of opioids relieving physiological cravings without negative effects. The extended-release injected therapy of buprenorphine for weekly and monthly subcutaneous injections for moderate to severe opioid use disorder was recently accepted by the FDA.
Jobs:
Senior Manager, Human Resources Plymouth Meeting, PA|23 days ago
Regional Director - West Remote|33 days ago
Regional Director - East Remote|33 days ago
Key Account Manager - Dayton, OH Remote - Dayton, OH|53 days ago
Key Account Manager - Los Angeles, CA Remote - Los Angeles, CA|75 days ago
Key Account Manager - Chicago, IL South Remote - Chicago, IL South|82 days ago